Brinton, E. A., Ballantyne, C. M., Bays, H. E., Kastelein, J. J., Braeckman, R. A., & Soni, P. N. (2013). Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: The ANCHOR study. BioMed Central.
Citação norma ChicagoBrinton, Eliot A., Christie M. Ballantyne, Harold E. Bays, John J. Kastelein, Rene A. Braeckman, and Paresh N. Soni. Effects of Icosapent Ethyl On Lipid and Inflammatory Parameters in Patients With Diabetes Mellitus-2, Residual Elevated Triglycerides (200–500 mg/dL), and On Statin Therapy At LDL-C Goal: The ANCHOR Study. BioMed Central, 2013.
Citação norma MLABrinton, Eliot A., et al. Effects of Icosapent Ethyl On Lipid and Inflammatory Parameters in Patients With Diabetes Mellitus-2, Residual Elevated Triglycerides (200–500 mg/dL), and On Statin Therapy At LDL-C Goal: The ANCHOR Study. BioMed Central, 2013.